 |
 |
 |
 |
 |
 |
 |
 |
 |
|
   |
|||||||||
 |
|||||||||
----------------------------------------------------------
November 2006
Avontec's lead product AVT-01 advances into multiple-dosing Phase 2a studies in asthma.
(PDF)
March 2006
Avontec GmbH starts new research laboratory at Heidelberg University
(PDF)
August 2005
Avontec GmbH raises Euro 14.5 million in a Series B financing round led by a fund, co-founded by AnGes MG and Nikko Principal Investments(PDF)
October 2003
Avontec's First Compound to Enter Clinical Development (PDF)
September 2003
Avontec Receives Key Patent in the US (PDF)
June 2003
Avontec Receives German Founders Award (PDF)
May 2003
Avontec GmbH and BIOTRONIK GmbH & Co. to Develop Jointly a Drug-Eluting Stent Based on a New Molecular Technology (PDF)
 |
 |
 |
 |
 |